Revvity Inc. $RVTY Shares Sold by Janney Montgomery Scott LLC

Janney Montgomery Scott LLC cut its holdings in Revvity Inc. (NYSE:RVTY) by 47.6% in the 1st quarter, according to its most recent 13F filing with the SEC. The fund owned 5,260 shares of the company’s stock after selling 4,782 shares during the period. Janney Montgomery Scott LLC’s holdings in Revvity were worth $461,000 at the end of the most recent reporting period.

A number of other large investors also recently made changes to their positions in the business. Louisiana State Employees Retirement System purchased a new position in Revvity during the first quarter worth approximately $508,000. Contravisory Investment Management Inc. purchased a new stake in shares of Revvity during the 1st quarter valued at $66,000. Assenagon Asset Management S.A. acquired a new stake in shares of Revvity during the 1st quarter worth $2,105,000. Vaughan Nelson Investment Management L.P. acquired a new stake in shares of Revvity during the 1st quarter worth $40,411,000. Finally, Corient Private Wealth LLC raised its position in shares of Revvity by 985.0% in the 4th quarter. Corient Private Wealth LLC now owns 126,568 shares of the company’s stock worth $12,245,000 after buying an additional 114,903 shares during the period. Hedge funds and other institutional investors own 86.65% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on the company. Barclays upped their price target on Revvity from $95.00 to $105.00 and gave the stock an “equal weight” rating in a research note on Thursday, May 7th. TD Cowen reiterated a “buy” rating on shares of Revvity in a report on Wednesday. Wall Street Zen downgraded shares of Revvity from a “buy” rating to a “hold” rating in a research report on Saturday, April 18th. Sanford C. Bernstein assumed coverage on shares of Revvity in a report on Friday, June 26th. They issued a “market perform” rating and a $115.00 price target on the stock. Finally, Wolfe Research initiated coverage on shares of Revvity in a research report on Tuesday, June 2nd. They set a “peer perform” rating on the stock. Four analysts have rated the stock with a Buy rating, ten have given a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Revvity has a consensus rating of “Hold” and an average target price of $108.92.

Revvity Trading Up 0.2%

Revvity stock opened at $111.43 on Thursday. The firm’s 50-day moving average is $103.12 and its 200-day moving average is $98.97. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.41 and a current ratio of 1.72. Revvity Inc. has a 1 year low of $81.22 and a 1 year high of $118.30. The company has a market cap of $12.43 billion, a P/E ratio of 53.32, a PEG ratio of 2.19 and a beta of 1.09.

Revvity (NYSE:RVTY) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $1.06 earnings per share for the quarter, beating analysts’ consensus estimates of $1.02 by $0.04. The business had revenue of $711.12 million during the quarter, compared to the consensus estimate of $704.07 million. Revvity had a net margin of 8.26% and a return on equity of 8.00%. The company’s revenue for the quarter was up 7.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.01 EPS. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS. On average, equities analysts expect that Revvity Inc. will post 5.25 earnings per share for the current year.

Revvity Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, August 7th. Stockholders of record on Friday, July 17th will be issued a dividend of $0.07 per share. The ex-dividend date of this dividend is Friday, July 17th. This represents a $0.28 annualized dividend and a dividend yield of 0.3%. Revvity’s dividend payout ratio is 13.40%.

Revvity Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.